A Single Rising Dose Study of MK-8150 (MK-8150-001)

NCT01590810 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Isolated Systolic Hypertension (ISH)

Interventions

DRUG: MK-8150 2.0 mg
DRUG: MK-8150 10 mg
DRUG: MK-8150 40 mg
DRUG: MK-8150 90 mg
DRUG: MK-8150 5.0 mg
DRUG: MK-8150 20 mg
DRUG: MK-8150 60 mg
DRUG: MK-8150 120 mg
DRUG: MK-8150 160 mg
DRUG: MK-8150 320 mg
DRUG: MK-8150 600 mg
DRUG: MK-8150 900 mg
DRUG: MK-8150 1200 mg
DRUG: Placebo for MK-8150
DRUG: MK-8150 50 mg
DRUG: MK-8150 100 mg
DRUG: MK-8150 200 mg
DRUG: MK-8150 400 mg
DRUG: MK-8150 500 mg

Sponsor

Merck Sharp & Dohme LLC